Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
Clinical trial NCT02118987 · COMPLETED
Trial details
- NCT number
- NCT02118987
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2017-12-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.